Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market performance.

Jupiter Life Line Hospitals Ltd has experienced a nuanced shift in its technical parameters, moving from a bearish to a mildly bearish trend. Despite a notable 3.74% gain in the latest session, the stock’s momentum indicators and moving averages suggest cautious optimism amid persistent headwinds in the hospital sector.

Jupiter Life Line Hospitals Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The company’s recent downgrade from a Hold to a Sell rating by MarketsMOJO, coupled with a 2.96% decline in its share price, underscores growing investor caution amid mixed market signals and subdued price performance relative to benchmarks.

Jupiter Life Line Hospitals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Jupiter Life Line Hospitals Ltd has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 1.45%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other trend analyses. This article delves into the detailed technical parameters and market context to provide investors with a comprehensive understanding of the stock’s current positioning.

Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1152.05 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors. The stock has underperformed its sector and key benchmarks over the past year, reflecting a challenging period for the hospital sector player.

Jupiter Life Line Hospitals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Jupiter Life Line Hospitals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Jupiter Life Line Hospitals Ltd has declined to a fresh 52-week low of Rs.1216.2, marking a significant downturn in its stock price amid broader market fluctuations and company-specific performance factors.

Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1230.05 today, marking a significant decline in its share price amid broader market fluctuations and sectoral underperformance. The stock’s fall to this level reflects a continuation of its subdued trend over the past year, contrasting with the relatively stronger performance of the benchmark indices.

Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1230.05 today, marking a significant decline in its stock price amid broader market fluctuations and sector-specific pressures. The stock underperformed its hospital sector peers and the broader market indices, reflecting ongoing concerns about its recent financial performance and valuation metrics.

Jupiter Life Line Hospitals Ltd’s share price declined to a fresh 52-week low of Rs.1238.3 today, marking a significant milestone in the stock’s recent performance. This new low reflects ongoing pressures on the company’s valuation amid broader market dynamics and sector-specific factors.

Jupiter Life Line Hospitals Ltd has touched a new 52-week low of Rs.1245.15 today, marking a significant decline in its share price amid broader market fluctuations. The stock has underperformed its sector and key benchmarks, reflecting ongoing concerns about its recent financial performance and valuation metrics.

Jupiter Life Line Hospitals Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a deteriorating market outlook. Despite solid operational metrics, the stock has seen a decline in price and a downgrade in its overall mojo rating, reflecting growing investor caution in the hospital sector.

Jupiter Life Line Hospitals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 17 Dec 2025, reflecting a shift from the previous Hold rating. However, the analysis and financial metrics discussed here represent the stock’s current position as of 01 February 2026, providing investors with the latest insights into its performance and outlook.

Jupiter Life Line Hospitals Ltd., a Mumbai-based hospital chain with a market capitalisation of ₹8,412 crores, reported a robust 30.67% quarter-on-quarter surge in consolidated net profit to ₹57.35 crores in Q2 FY26, up from ₹43.89 crores in Q1 FY26. On a year-on-year basis, profits grew 11.04%, demonstrating sustained momentum in the company's expansion trajectory. However, the stock has struggled to translate operational gains into market returns, declining 15.50% over the past year whilst trading at a premium valuation of 44 times trailing earnings.